n/a
Article Publish Status: FREE
Abstract Title:

Diversity ofCNCM I-745 mechanisms of action against intestinal infections.

Abstract Source:

World J Gastroenterol. 2019 May 14 ;25(18):2188-2203. PMID: 31143070

Abstract Author(s):

Dorota Czerucka, Patrick Rampal

Article Affiliation:

Dorota Czerucka

Abstract:

The yeastCNCM I-745 is one of the probiotics recommended for the prevention of antibiotic-associated diarrhea. Studies conductedanddemonstrated that in the case of infectious diseases there are two potential sites of action ofCNCM I-745: (1) An action on enteropathogenic microorganisms (adhesion of bacteria and their elimination or an effect on their virulence factors: Toxins, lipopolysaccharide,.); and (2) a direct action on the intestinal mucosa (trophic effects, effects on epithelial reconstitution, anti-secretory effects, anti-inflammatory, immunomodulators). Oral administration ofCNCM I-745 to healthy subjects does not alter their microbiota. However, in the case of diseases associated with the use of antibiotics or chronic diarrhea,CNCM I-745 can restore the intestinal microbiota faster. The interaction ofCNCM I-745 with the innate immune system have been recently demonstrated thus opening up a new therapeutic potential of this yeast in the case of diseases associated with intestinal infections but also other pathologies associated with dysbiosis such as inflammatory diseases.

Print Options


This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.